Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Sera Prognostics Inc chart...

About the Company

sera prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. sera’s tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. the company has assembled a strong management team and board of directors with significant clinical development and women’s healthcare diagnostic experience. the company is supported by a strong group of investors, including the bill & melinda gates foundation, chione, ltd, domain associates, interwest partners, catalyst health ventures, upstart life sciences capital, and osage university partners. the company is working with the bill & melinda gates foundation to translate its discoveries and develop technologies to benefit women and infants in underserved countries worldwide. sera prognostics is located in salt lake city, utah. sera launched its first diagnos

Exchange

NASDAQ

Website

pretrm.com

$8M

Total Revenue

96

Employees

$0M

Market Capitalization

-8.02

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $SERA News

Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2023 Earnings Call Transcript

7d ago, source:

Q4 2023 Earnings Call March 20, 2024 Sera Prognostics, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations ...

Sera Prognostics Inc Class A SERA

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates

8d ago, source:

Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.25 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago. These figures are ...

Chief Scientific Officer John Boniface Sells 77,136 Shares of Sera Prognostics Inc (SERA)

3h ago, source:

John Boniface, the Chief Scientific Officer of Sera Prognostics Inc (NASDAQ:SERA), has sold 77,136 shares of the company on ...

Sera Prognostics To Present at TD Cowen 44th Annual Healthcare Conference

28d ago, source: Nasdaq

SALT LAKE CITY, Feb. 29, 2024 /PRNewswire/ --Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy ...

Sera Prognostics, Inc.: Sera Prognostics Reports Fourth Quarter 2023 Financial Results

8d ago, source:

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker ...

Sera Prognostics (SERA) Upgraded to Buy: Here's What You Should Know

3d ago, source: Zacks.com on MSN

Sera Prognostics, Inc. (SERA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

Sera Prognostics, Inc (SERA) Q4 2023 Earnings Call Transcript

8d ago, source: Seeking Alpha

Good afternoon and welcome to the Sera Prognostics Conference Call to Review Fourth Quarter Fiscal Year 2023 Results. At this time, all participants are in listen-only mode. We will be ...

Sera Prognostics Inc Class A

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...